Source abstract
Abstract
Membrane proteins (MPs) play important roles in various cellular processes and are major targets for drugs. Solubilization of MPs is often needed for structural and biophysical studies. For high-resolution nuclear magnetic resonance measurements, there is a size limit of the sample (<100 kDa), and a high thermal stability at an increased temperature is required. Furthermore, lipid bilayer-like environments are desirable to preserve the native states of MPs. However, existing solubilization techniques do not fulfill these requirements at the same time. In this study, we combined two phospholipid analogues as a solubilizer and stabilizer to isolate MPs. This method maintained bacteriorhodopsin (bR) extracted from purple membranes in its native state for 7 d at 40 °C. The solubility was comparable to that of conventional detergents for MPs, and the thermal stability of the solubilizate was the best among them. The increase in the molecular size caused by the solubilization of bR was only 20 kDa, indicating that 20 phospholipid analogue molecules were sufficient to solubilize one bR molecule. 15 N– 1 H heteronuclear single quantum coherence spectra of solubilized 2 H- and 15 N-labeled bR gave ∼80% of the expected peaks. In addition, the lysate of human neuropeptide Y 2 receptor-expressing mammalian cells exhibited ligand recognition for 7 d at 37 °C, suggesting that this technique can be used for ligand screening. Moreover, the structure of the single membrane-spanning M2 protein of the influenza A virus expressed in Escherichia coli was stably maintained for 7 d at 40 °C. Thus, our method is promising for various MP studies.
Source: openalex_inverted_index · Quality: baseline
Affiliations
Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan
School of Pharmacy, Hyogo Medical University, Kobe 650-8530, Japan
Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Kyoto 606-8501, Japan
Research Center for Next-Generation Protein Sciences, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan
School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women’s University, Nishinomiya 663-8179, Japan
Funding
Takeda Science Foundation · Japan Agency for Medical Research and Development · Japan Society for the Promotion of Science